Form 4 for ABCL AbCellera Biologics Inc.
Accepted 2026-05-18 12:09:44 ET · period of report 2026-05-14 · accession 0001834423-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-18 12:09 | 2026-05-14 | ABCL | Montalbano John S. | Dir | P - Purchase | $4.77 | +20.0K | 241.0K | +9% | +$95.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2026-05-14 | P | A | 20,000 | $4.77 | 241,000 | D | — | — |